Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic
Novel Hormonal Therapies for Prostate Cancer - WATCH THE VIDEO. Dr. Alan H. Bryce, MD, discusses the newest advances and research in prostate cancer treatments that target androgen receptors, such as BET inhibitors and CYP17 inhibitors, as opposed to chemotherapeutic and radiopharmaceutical approaches. Video credits to the YouTube channel owner
Potentially Harmful Chemicals In #BottledWater. “An increasing number of in vitro studies reports the presence of EDCs in bottled water. With previous studies focusing on estrogenicity, the present work provides evidence for an additional contamination with steroid receptor antagonists. Using an optimized extraction procedure, we detected antiestrogens and antiandrogens in the majority of analyzed bottled water products. Moreover, the antagonist activity was very potent. An equivalent of…
Ostarine is a selective androgen receptor modulator (SARM) that attaches to the androgen receptor in a similar way to anabolic steroids such as Testosterone, but in a more particular way. They demonstrate similar anabolic effects as with steroids, but minus the side effects that come with other androgens.